Evolent Health, Inc found using ticker (EVH) have now 5 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The range between the high target price and low target price is between 44 and 32 with the average target price sitting at 37.6. Given that the stocks previous close was at 26.65 this now indicates there is a potential upside of 41.1%. The 50 day MA is 24.64 while the 200 day moving average is 24.81. The market capitalisation for the company is $2,489m. You can visit the company’s website by visiting: https://www.evolenthealth.com
The potential market cap would be $3,511m based on the market concensus.
Evolent Health, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; and delivery network alignments. This segment also offers specialty care management solutions that support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation, and specific market dynamics; and comprehensive health plan administrative services that helps providers assemble the complete infrastructure required to operate, manage, and capitalize on a variety of financial and administrative management services. The True Health segment operates a commercial health plan for small and large businesses in New Mexico. Evolent Health was founded in 2011 and is headquartered in Arlington, Virginia.
